Pivotal role of augmented αB-crystallin in tumor development induced by deficient TSC1/2 complex

F Wang1, X Chen1, C Li1

  • 1State Key Laboratory of Medical Molecular Biology, Department of Physiology and Pathophysiology, Institute of Basic Medical Sciences and School of Basic Medicine, Graduate School of Peking Union Medical College, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.

Oncogene
|October 1, 2013
PubMed

Insights

Tuberous sclerosis complex (TSC) is linked to mTOR signaling. Upregulated αB-crystallin drives TSC tumor growth by promoting cell migration and invasion. Inhibiting αB-crystallin may offer new therapeutic strategies for TSC.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Tuberous sclerosis complex (TSC) is a genetic disorder characterized by benign tumor formation in multiple organs.
  • Mutations in TSC1 or TSC2 genes lead to hyperactivation of mechanistic target of rapamycin (mTOR) signaling.
  • mTOR signaling, mediated by mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2), plays a crucial role in cell growth and proliferation.

Purpose of the Study:

  • To investigate the role of αB-crystallin in TSC pathogenesis.
  • To elucidate the signaling pathways regulating αB-crystallin expression in TSC.
  • To evaluate the therapeutic potential of targeting αB-crystallin in TSC.

Main Methods:

  • Analysis of αB-crystallin expression in various TSC models, including cell lines and tumors.
  • Investigation of the transcriptional regulation of αB-crystallin by the mTORC2:NFκB signaling pathway.
  • Functional assays to assess the impact of αB-crystallin on cell migration, invasion, proliferation, and tumorigenesis.

Main Results:

  • αB-crystallin expression was significantly upregulated in Tsc1/2-deficient cells and TSC-associated tumors.
  • mTORC2:NFκB signaling cascade was identified as the transcriptional activator of αB-crystallin.
  • Enhanced αB-crystallin expression promoted migration, invasion, and apoptosis resistance in Tsc2-deficient cells.
  • Disruption of αB-crystallin suppressed proliferation and tumorigenesis in Tsc2-null cells.

Conclusions:

  • αB-crystallin is a key mediator of tumorigenesis in TSC1/2 complex deficiency.
  • Targeting αB-crystallin represents a potential therapeutic strategy for TSC.
  • Understanding the αB-crystallin regulatory network offers insights into TSC pathogenesis.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...